Classical scrapie is one of the transmissible spongiform encephalopathies (TSEs), a group of fatal infectious diseases that affect the central nervous system (CNS). Classical scrapie can transmit laterally from ewe to lamb perinatally or between adult animals. Here we report detection of infectivity in tissues of an unborn fetus, providing evidence that in utero transmission of classical scrapie is also possible.
T ransmissible spongiform encephalopathies (TSEs) are chronic, fatal neurodegenerative diseases affecting animals and humans. The causative agent of TSEs is considered to be PrP Sc , a pathogenic isoform of a normal host protein (PrP C ). However, detectable PrP Sc may not always be associated directly with infectivity and proof of infectivity is considered to be the most reliable method for determining the true infectious potential of a tissue (1) (2) (3) .
Classical scrapie (c-scrapie) is a TSE affecting small ruminants. In addition to the central nervous system, various peripheral tissues and natural body secretions can harbor PrP Sc and infectivity (4, 5) . However, susceptibility to c-scrapie and peripheral distribution of the agent are strongly influenced by the PrP amino acid sequence, and in sheep, valine at codon 136 confers the greatest susceptibility to disease and widespread distribution of prions in peripheral tissues (6, 7) .
Environmental contamination is believed to be a major contributor to lateral transmission of c-scrapie, with oral ingestion being a major route of entry of the agent into the host (5-7). Although c-scrapie can be transmitted laterally and susceptible adult animals can be infected if they are exposed to the agent, the disease can also be transmitted maternally via ingestion of the agent either directly (consumption of colostrum or milk) or indirectly (close contact with the placenta) (8) (9) (10) (11) . Here, we provide evidence that prenatal exposure to the agent can also occur, and lead to infection in utero, by demonstrating infectivity in fetal tissues from a dam infected with c-scrapie.
All sheep in this study were bred and reared in the Animal Health and Veterinary Laboratories Agency (AHVLA) Ripley flock, which was created from sheep purchased from commercial flocks with a high prevalence of scrapie and managed, using methods such as genotype selection, to maximize TSE prevalence. In other respects, commercial farming practices were applied in order to study the disease in conditions as close as possible to its natural environment. All animal procedures were carried out in accordance with the Animals (Scientific Procedures) Act 1986 under Home Office licence numbers 70/5780 (ruminant experimentation) and 70/6310 (mouse bioassays) and were approved by the local ethics committee of AHVLA.
One VRQ/VRQ ewe was allowed to mate naturally with a VRQ/VRQ ram. Another two VRQ/VRQ ewes were inseminated artificially with semen from a VRQ/VRQ ram. Details of the ewes and the resulting fetuses are presented in Tables 1 and 2 , respectively. All three ewes were euthanized at the fourth month of gestation by an overdose of sodium pentobarbital administered intravenously followed by exsanguination. At this point, one ewe had already been exhibiting clinical signs of c-scrapie, while the other two were asymptomatic. Postmortem, the gravid uterus was removed aseptically and processed separately from the remainder of the carcass. Placentome, amniotic fluid, allantoic fluid, umbilical cord, fetal mesenteric lymph node (MLN), fetal spleen, and fetal liver were each sampled using new, disposable sterile instruments to prevent cross-contamination between tissues. Brain samples from the ewes were immersed in formal saline and processed routinely for histology and immunohistochemistry (IHC) with the anti-PrP monoclonal antibody R145. Fetal tissues were also fixed and immunolabeled with R145 diluted 1/500.
Samples for bioassay were kept frozen at Ϫ80°C until they were homogenized in normal saline (10%, wt/vol) to produce inocula. All inocula were tested microbiologically and were treated with antibiotics if required. After microbiological clearance, inocula were refrozen at Ϫ80°C until they were used to challenge transgenic tg338 mice, which overexpress an ovine PrP VRQ transgene on a murine PrP null background (12) . Each mouse received 20 l of homogenate intracerebrally and 100 l intraperitoneally. Mice were monitored for clinical signs of neurological disease and were (Fig. 1 ).
PrP
Sc was also detectable in the placentomes of all four fetuses (one ewe was carrying twins). No PrP Sc deposits were detected in the umbilical cord and the tissues (mesenteric lymph node, spleen, liver) of the four fetuses. For three of the four fetuses, the bioassay results were in agreement with the IHC observations. However, tg338 mice challenged with umbilical cord or mesenteric lymph node from a single fetus did succumb to TSE despite a negative IHC result in the respective tissues (Table 3) .
Thirteen of 18 mice (72%) inoculated with umbilical cord from the affected fetus were TSE positive, but only 3 of 10 mice (30%) inoculated with MLN were positive by IHC (Table 3) . These data are indicative of an ascending infection from the placenta to the fetus. These data demonstrate in utero transmission of c-scrapie based on proof of infectivity and are in agreement with a report that identified PrP Sc in fetal tissues after protein misfolding cyclic amplification (PMCA) (13) . In our view, in utero transmission probably requires peripheral distribution of PrP Sc and therefore it is a risk only in animals where peripheral PrP Sc distribution, or at least TSE infectivity, can be demonstrated, particularly in the placenta. C-scrapie is an example of such a TSE, although peripheral distribution of the agent is a function of the PrP genotype (6, 7) .
In this study, we used sheep with the genotype VRQ/VRQ, which are considered to be the most susceptible to c-scrapie and which show the most widespread and abundant PrP Sc in peripheral tissues (7, 11, 14) . All three dams were positive postmortem, but only one had reached clinical disease. Nevertheless, placentomes from all four fetuses were positive on bioassay, although infectivity was detected in tissues from only a single fetus. The other three fetuses, including the one that was recovered from the ewe that showed clinical signs, were negative. Possibly the infectivity levels in these fetuses or in the PrP Sc -negative tissues from the affected fetus were below detection level. It is logical to assume that if the fetuses were allowed to develop further and be born a higher incidence of infectivity could have been detected. This assumption is further supported by the fact that the ewes were euthanized at the fourth month of gestation, when the distribution of PrP Sc in the placentomes was restricted compared to that in full-term pregnancy (Fig. 1) .
The possibility of in utero transmission has also been proposed for chronic wasting disease (CWD) in cervids, where accumulation of PrP Sc in the peripheral tissues is a common finding (15) . Similar peripheral accumulation of PrP Sc in small ruminants affected experimentally with bovine spongiform encephalopathy (BSE) means that in these species the possibility of in utero BSE transmission cannot be dismissed (16, 17) . Peripheral accumulation of PrP Sc has also been demonstrated in variant CreutzfeldtJakob disease (CJD) cases and asymptomatic carriers have been detected (18) (19) (20) , so theoretically, in utero transmission in humans cannot be excluded unequivocally although there are histological and physiological differences between human and ruminant placentae. However, with our current knowledge, it is not possible to conclude whether the human placenta confers better protection to the conceptus from TSEs or not.
The data presented here raise questions regarding the efficiency of current control measures for the eradication of animal TSEs, which have been based on the assumption that TSEs do not transmit in utero. They also indicate that the risk analysis approaches regarding TSEs with evident peripheral distribution of PrP Sc may have to be reviewed, although more research is required to increase the amount of information available in order to quantify the risk.
